Renal Disease in Primary Sjögren’s Syndrome

被引:0
作者
Oshorenua Aiyegbusi
Laura McGregor
Lucy McGeoch
David Kipgen
Colin C. Geddes
Kathryn I. Stevens
机构
[1] Queen Elizabeth University Teaching Hospital,Glasgow Renal and Transplant Unit
[2] Glasgow Royal Infirmary,Pathology Department
[3] Queen Elizabeth University Teaching Hospital,undefined
来源
Rheumatology and Therapy | 2021年 / 8卷
关键词
Glomerulonephritis; Kidney disease; Sjögren’s syndrome; Tubular dysfunction; Tubulointerstitial nephritis;
D O I
暂无
中图分类号
学科分类号
摘要
Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disorder characterised by lymphocytic infiltration of the exocrine glands, predominantly the salivary and lacrimal glands, leading to sicca symptoms. Patients may have extraglandular disease involving multiple organs, including the kidneys. 5% of patients with pSS can have renal involvement. Kidney disease in pSS presents a diagnostic challenge, as clinical symptoms are often insidious and can precede sicca symptoms. pSS affects the kidney through lymphocytic infiltration of renal tubules or immune complex deposition, leading to an array of clinical features. Tubulointerstitial nephritis is the most common histological pattern of kidney disease. Other tubular injuries include renal tubular acidosis with hypokalaemia, Fanconi’s syndrome and diabetes insipidus. Glomerular disease is less common and typically involves an immune complex-mediated process. Optimal treatment for kidney diseases in pSS is not established, and treatment is guided by the pattern of disease. For tubulointerstitial nephritis, management involves electrolyte imbalance correction and the use of immunosuppression, including steroids. Treatment of glomerular disease is targeted to the histological pattern, and often requires a combination of immunosuppressive agents. The risk of end-stage kidney disease is low. Nevertheless, patients with pSS and kidney disease have significantly reduced quality of life.
引用
收藏
页码:63 / 80
页数:17
相关论文
共 257 条
[1]  
Patel R(2014)The epidemiology of Sjögren’s syndrome Clin Epidemiol 6 247-255
[2]  
Shahane A(2017)Sjogren’s syndrome: clinical aspects Clin Immunol 182 48-54
[3]  
Vivino FB(2018)Primary Sjögren’s syndrome Lupus 27 32-35
[4]  
Bowman SJ(2008)Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients Med (Baltim) 87 210-219
[5]  
Ramos-Casals M(2008)Renal involvement and followup of 130 patients with primary Sjögren’s syndrome J Rheumatol 35 278-284
[6]  
Solans R(2002)Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group Ann Rheum Dis 61 554-558
[7]  
Rosas J(2016)Renal involvement in primary Sjögren syndrome Nature Rev Nephrol 12 82-93
[8]  
Camps MT(2001)Clinical and morphological features of kidney involvement in primary Sjögren’s syndrome Nephrol Dial Transplant 16 2328-2336
[9]  
Gil A(2010)Clinical and prognostic characteristics of 573 cases of primary Sjögren’s syndrome Chin Med J (Engl) 123 3252-3257
[10]  
Del Pino-Montes J(2018)Renal involvement in primary Sjogren’s syndrome: a prospective cohort study Rheumatol Int 38 2251-2262